IDEAYA Biosciences (IDYA) Cash from Operations Growth (1y) (2019 - 2026)
IDEAYA Biosciences (IDYA) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 158.60% |
| 10 | IDEAYA Biosciences | 3.22 Bn | 2.54 Bn | - | -24.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.57% |
| Dec 31, 2025 | 25.61% |
| Sep 30, 2025 | 388.85% |
| Jun 30, 2025 | -89.99% |
| Mar 31, 2025 | -37.73% |
| Dec 31, 2024 | -412.27% |
| Sep 30, 2024 | -63.17% |
| Jun 30, 2024 | 1.73% |
| Mar 31, 2024 | -57.36% |
| Dec 31, 2023 | -1.62% |
| Sep 30, 2023 | -24.86% |
| Jun 30, 2023 | -67.37% |
| Mar 31, 2023 | -41.71% |
| Dec 31, 2022 | -40.30% |
| Sep 30, 2022 | -93.82% |
| Jun 30, 2022 | -54.62% |
| Mar 31, 2022 | -43.16% |
| Dec 31, 2021 | -43.64% |
| Sep 30, 2021 | -113.82% |
| Jun 30, 2021 | 4.97% |